A fixed sequence, two period crossover study, in healthy volunteer to evaluate the drug interaction between tenofovir alafenamide, emtricitabine and ritonavir boosted atazanavir or darunavir or lopinavir or dolutegravir

Trial Profile

A fixed sequence, two period crossover study, in healthy volunteer to evaluate the drug interaction between tenofovir alafenamide, emtricitabine and ritonavir boosted atazanavir or darunavir or lopinavir or dolutegravir

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Oct 2015

At a glance

  • Drugs Tenofovir alafenamide (Primary) ; Atazanavir/ritonavir; Darunavir/ritonavir; Dolutegravir; Emtricitabine; Lopinavir/ritonavir
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 16 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top